Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
机构:[1]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.[2]Department of Rheumatology and Immunology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.[3]Department of Rheumatology, Hainan General Hospital, Haikou, China.[4]Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.[5]Department of Rheumatology Institute of Immunology and Rheumatology Inner Mongolia Key Laboratory of Autoimmunity, The First Affiliated Hospital of Baotou Medical College, Baotou Medical College, Baotou, China.内蒙古科技大学包头医学院[6]Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.[7]Department of Clinical Immunology and Rheumatology, Xijing Hospital Affiliated to the Fourth Military Medical University, Xi'an, China.[8]Department of Rheumatology, First Affiliated Hospital of Kunming Medical University, Kunming, China.昆明医科大学附属第一医院[9]Department of Rheumatology, Affiliated Hospital of Inner Mongolia Medical College, Hohhot, China.[10]Department of Rheumatology and Immunology, Nanfang Hospital, Southern Medical University, Guangzhou, China.[11]Department of Rheumatology, The First Affiliated Hospital of Nanchang University, Nanchang, China
Chinese National Key Technology R&D Program,
Ministry of Science and Technology (2021YFC2501300), Beijing Municipal
Science & Technology Commission (No.Z201100005520022,23, 25–27),
CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-I2M-1–005), and
National High Level Hospital Clinical Research Funding (2022-PUMCH-B-013,
C-002, D-009).
第一作者机构:[1]Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Cheng Cheng,Huang Can,Chen Zhen,et al.Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII[J].ARTHRITIS RESEARCH & THERAPY.2023,25(1):78.doi:10.1186/s13075-023-03061-3.
APA:
Cheng Cheng,Huang Can,Chen Zhen,Zhan Feng,Duan Xinwang...&Zeng Xiaofeng.(2023).Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII.ARTHRITIS RESEARCH & THERAPY,25,(1)
MLA:
Cheng Cheng,et al."Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII".ARTHRITIS RESEARCH & THERAPY 25..1(2023):78